Work for Nemaura Medical Inc.?

Claim Your Profile

Nemaura Medical Inc. Logo Image

Nemaura Medical Inc.

About Nemaura Medical Inc.

11-50 Employees
Based in New York City, New York

Nemaura Medical Inc. is a medical technology company developing and commercializing non-invasive wearable diagnostic devices. The company is currently commercializing sugarBEAT®, BEAT™diabetes, and proBEAT™. sugarBEAT®, a CE mark approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor (CGM) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which may help people with diabetes and pre-diabetes to better manage, reverse, and prevent the onset of diabetes. Nemaura has submitted a PMA (Premarket Approval Application) for sugarBEAT® to the U.S. FDA. proBEAT™ combines non-invasive glucose data processed using artificial intelligence and a digital healthcare subscription service and is expected to be launched in the U.S. as a general wellness product.

Ticker:
NMRD
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Medical Appliances & Equipment (See More Medical Appliances & Equipment Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol